07:56 AM EDT, 08/26/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) on Tuesday said the mechanism of action of its next generation personalized off-the-shelf immunotherapy has been published in the peer-reviewed open-access journal, JCI Insight. The research, which was conducted in collaboration with the National Cancer Institute (NCI), validates the core design principle behind Bria-OTS+ platform, a statement said....

MOSCOW (Reuters) -Russia hopes that a U.S.-Russian joint venture involving Boeing in the Sverdlovsk region can resume its operations, Russian First Deputy Prime Minister Denis Manturov told the TASS state news agency in an interview. The joint venture between Russia's largest titanium maker VSMPO-AVISMA and U.S. aircraft manufacturer Boeing halted operations in 2022 after Boeing decided to suspend purchases of...

07:55 AM EDT, 08/26/2025 (MT Newswires) -- Curanex Pharmaceuticals (CURX) said Tuesday it priced its initial public offering of 3.75 million common shares at $4 each, for gross proceeds of $15 million. IPO underwriters have a 45-day overallotment option to acquire up to 562,500 additional shares. The developmental-stage pharmaceutical company said it expects its shares to start trading on the...

07:55 AM EDT, 08/26/2025 (MT Newswires) -- Stellantis ( STLA ) has axed its first Level 3 advanced driver-assistance program due to high costs, technology issues, and concerns over market viability, Reuters reported Tuesday, citing three sources familiar with the matter. According to Reuters, a Stellantis ( STLA ) spokesperson said the L3 technology that was announced in February has...